Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Study in Human iPSCs-derived Retinal Pigment Epithelium Cells Transplantation for Advanced (Late-stage) Age-Related Macular Degeneration

Authors not listed

The First Affiliated Hospital with Nanjing Medical University · 2025

Abstract

Phase I Study of the Safety and Preliminary Efficacy of Human induced pluripotent stem cells-derived Retinal Pigment Epithelial Cells (hiPSC-RPEs) Subretinal Transplantation in Adanced (Late-Stage) Age-Related Macular Degeneration(AMD) Patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2025). Study in Human iPSCs-derived Retinal Pigment Epithelium Cells Transplantation for Advanced (Late-stage) Age-Related Macular Degeneration. <em>The First Affiliated Hospital with Nanjing Medical University</em>. https://clinicaltrials.gov/study/NCT07418177
Vancouver
Anonymous. Study in Human iPSCs-derived Retinal Pigment Epithelium Cells Transplantation for Advanced (Late-stage) Age-Related Macular Degeneration. The First Affiliated Hospital with Nanjing Medical University. 2025.
BibTeX
@misc{anon2025Studyi, title = {Study in Human iPSCs-derived Retinal Pigment Epithelium Cells Transplantation for Advanced (Late-stage) Age-Related Macular Degeneration}, author = {Anonymous}, journal = {The First Affiliated Hospital with Nanjing Medical University}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings